https://www.selleckchem.com/pr....oducts/telratolimod.
Thirteen DEGs selected as the targets for qRT-PCR validation showed significant differential expressions in IDD ( 0.001), and their expression trends were all consistent with the results of RNA-seq. Among these genes, 10 genes showed significant intergroup fold change (Log2FoldChange1). ECM, growth factors, collagen components, inflammatory chemokines and such signal pathways as TNF-α and PI3K-Akt all have important contributions to IDD progression and may thus serve as new therapeutic targets for treatment of IDD. ECM, gr
Like
Comment
Share
